Ignite Creation Date:
2024-05-05 @ 11:29 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00057720
Status:
COMPLETED
Last Update Posted:
2011-07-25
First Post:
2003-04-07
Brief Title:
TLK286 Telcyta vs DoxilCaelyx or Hycamtin in Platinum Refractory or Resistant Ovarian Cancer
Sponsor:
Telik
Organization:
Telik
Organization Data
Organization:
Telik
Class:
INDUSTRY
Study ID:
TLK2863017
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Telik
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Gail Brown MD Chief Medical Officer
Old Organization:
Telik Inc